About: covid:PMC7223540

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7223540 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Gauthier, Serge Vellas, B. Aisen, P.S. Cummings, J. Detke, M.J. Longo, F.M. Raman, R. Sabbagh, M. Schneider, L. Tanzi, R. Tariot, P. Touchon, J. Weiner, M.
is schema:about of	named entity 'Disease' named entity 'proinflammatory' named entity 'neuron degeneration' named entity 'Multi-domain' named entity 'Goal Attainment Scaling' named entity 'tauopathies' named entity 'gingipain' named entity 'alternative treatment' named entity 'misfolding' named entity 'microbial' named entity 'CBD' named entity 'microbial infections' named entity 'microbe' named entity 'amyloid' named entity 'microbial' named entity 'MCI' named entity 'dementia' named entity 'Roche' named entity 'retrospective cohort study' named entity 'CSF' named entity 'animal studies' named entity 'tau protein' named entity 'Europe' named entity 'blood pressure' named entity 'plasma levels' named entity 'pathogenesis' named entity 'mild cognitive impairment' named entity 'p75NTR' named entity 'neurotoxicity' named entity 'cell surface receptors' named entity 'tolerability' named entity 'cognition' named entity 'PSP' named entity 'physiological' named entity 'HSV1' named entity 'biomarkers of aging' named entity 'human brain' named entity 'oligomerization' named entity 'MCI' named entity 'animal models' named entity 'Huntington’s disease' named entity 'Herpes simplex virus' named entity 'Phase 2 studies' named entity 'Phase 2' named entity 'therapeutic targets' named entity 'phenotype' named entity 'Genentech' named entity 'cognitive decline' named entity 'amyloid' named entity 'obesity' named entity 'photobiomodulation' named entity 'pathology' named entity 'metabolic' named entity 'positron emission tomography' named entity 'amyloid' named entity 'neuroinflammation' named entity 'amyloid' named entity 'mild cognitive impairment' named entity 'anti-inflammatories' named entity 'Canada' named entity 'neurodegeneration' named entity 'HSV' named entity 'oligomer' named entity 'neuroinflammation' named entity 'MAPT' named entity 'isoform' named entity 'risk factors' named entity 'seed' named entity 'p75NTR' named entity 'genetic evidence' named entity 'polyunsaturated fatty acid' named entity 'omega-3' named entity 'neurodegeneration' named entity 'therapeutic targets' named entity 'Phase 2 studies' named entity 'microbe' named entity 'intracellular trafficking' named entity 'cortical areas' named entity 'disease-modifying' named entity 'MAPT' named entity 'cognitive decline' named entity 'amyloid' named entity 'neurotrophins' named entity 'methylene blue' named entity 'clinical trials' named entity 'upstream and downstream' named entity 'tau'

Attributes

Values

Creator

Gauthier, Serge
Vellas, B.
Aisen, P.S.
Cummings, J.
Detke, M.J.
Longo, F.M.
Raman, R.
Sabbagh, M.
Schneider, L.
Tanzi, R.
Tariot, P.
Touchon, J.
Weiner, M.

is schema:about of

named entity 'Disease'
named entity 'proinflammatory'
named entity 'neuron degeneration'
named entity 'Multi-domain'
named entity 'Goal Attainment Scaling'
named entity 'tauopathies'
named entity 'gingipain'
named entity 'alternative treatment'
named entity 'misfolding'
named entity 'microbial'
named entity 'CBD'
named entity 'microbial infections'
named entity 'microbe'
named entity 'amyloid'
named entity 'microbial'
named entity 'MCI'
named entity 'dementia'
named entity 'Roche'
named entity 'retrospective cohort study'
named entity 'CSF'
named entity 'animal studies'
named entity 'tau protein'
named entity 'Europe'
named entity 'blood pressure'
named entity 'plasma levels'
named entity 'pathogenesis'
named entity 'mild cognitive impairment'
named entity 'p75NTR'
named entity 'neurotoxicity'
named entity 'cell surface receptors'
named entity 'tolerability'
named entity 'cognition'
named entity 'PSP'
named entity 'physiological'
named entity 'HSV1'
named entity 'biomarkers of aging'
named entity 'human brain'
named entity 'oligomerization'
named entity 'MCI'
named entity 'animal models'
named entity 'Huntington’s disease'
named entity 'Herpes simplex virus'
named entity 'Phase 2 studies'
named entity 'Phase 2'
named entity 'therapeutic targets'
named entity 'phenotype'
named entity 'Genentech'
named entity 'cognitive decline'
named entity 'amyloid'
named entity 'obesity'
named entity 'photobiomodulation'
named entity 'pathology'
named entity 'metabolic'
named entity 'positron emission tomography'
named entity 'amyloid'
named entity 'neuroinflammation'
named entity 'amyloid'
named entity 'mild cognitive impairment'
named entity 'anti-inflammatories'
named entity 'Canada'
named entity 'neurodegeneration'
named entity 'HSV'
named entity 'oligomer'
named entity 'neuroinflammation'
named entity 'MAPT'
named entity 'isoform'
named entity 'risk factors'
named entity 'seed'
named entity 'p75NTR'
named entity 'genetic evidence'
named entity 'polyunsaturated fatty acid'
named entity 'omega-3'
named entity 'neurodegeneration'
named entity 'therapeutic targets'
named entity 'Phase 2 studies'
named entity 'microbe'
named entity 'intracellular trafficking'
named entity 'cortical areas'
named entity 'disease-modifying'
named entity 'MAPT'
named entity 'cognitive decline'
named entity 'amyloid'
named entity 'neurotrophins'
named entity 'methylene blue'
named entity 'clinical trials'
named entity 'upstream and downstream'
named entity 'tau'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software